XBiotech XBIT
NASDAQ XBIT
$2.00 -0.12 (-5.66%)
At close: Oct 19, 2026 · 4:00 PM EDT

XBiotech (XBIT) Gross Margin (2020 - 2022)

Updated

XBiotech's Gross Margin came in at 83.77% for FY2022, up 15.41 percentage points from 68.36% in FY2021.

Analysis

XBiotech (XBIT) Gross Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Gross Margin at 68.36% in FY2021 (+46.88 pp) and 21.48% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 68.19%
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 74.74%
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 73.54%
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 78.02%
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 83.60%
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 72.04%
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 79.76%
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 72.78%
10 XBiotech 60.98 Mn -474.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 87.20%
Jun 30, 2022 86.47%
Mar 31, 2022 57.40%
Dec 31, 2021 76.76%
Sep 30, 2021 75.44%
Jun 30, 2021 69.94%
Mar 31, 2021 52.49%
Dec 31, 2020 57.34%
Sep 30, 2020 10.65%
Jun 30, 2020 14.82%
Mar 31, 2020 23.71%
API Access

XBiotech Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY